CN117569013A - Micro-nano fiber membrane containing collagen fibers and preparation method and application thereof - Google Patents
Micro-nano fiber membrane containing collagen fibers and preparation method and application thereof Download PDFInfo
- Publication number
- CN117569013A CN117569013A CN202311481754.9A CN202311481754A CN117569013A CN 117569013 A CN117569013 A CN 117569013A CN 202311481754 A CN202311481754 A CN 202311481754A CN 117569013 A CN117569013 A CN 117569013A
- Authority
- CN
- China
- Prior art keywords
- collagen
- micro
- fiber membrane
- nano fiber
- collagen fibers
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 102000008186 Collagen Human genes 0.000 title claims abstract description 151
- 108010035532 Collagen Proteins 0.000 title claims abstract description 151
- 229920001436 collagen Polymers 0.000 title claims abstract description 151
- 239000000835 fiber Substances 0.000 title claims abstract description 142
- 239000012528 membrane Substances 0.000 title claims abstract description 120
- 239000002121 nanofiber Substances 0.000 title claims abstract description 78
- 238000002360 preparation method Methods 0.000 title claims abstract description 21
- 238000009987 spinning Methods 0.000 claims abstract description 46
- 238000001523 electrospinning Methods 0.000 claims abstract description 36
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims abstract description 27
- 239000000243 solution Substances 0.000 claims abstract description 27
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 25
- 238000000034 method Methods 0.000 claims abstract description 23
- 230000002500 effect on skin Effects 0.000 claims abstract description 22
- 239000011159 matrix material Substances 0.000 claims abstract description 21
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 15
- 239000011259 mixed solution Substances 0.000 claims abstract description 13
- 230000037314 wound repair Effects 0.000 claims abstract description 9
- 239000007788 liquid Substances 0.000 claims description 20
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical group [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 14
- 239000002253 acid Substances 0.000 claims description 7
- 150000003841 chloride salts Chemical class 0.000 claims description 7
- 239000011780 sodium chloride Substances 0.000 claims description 7
- 239000003814 drug Substances 0.000 claims description 2
- 229940079593 drug Drugs 0.000 claims description 2
- 239000003658 microfiber Substances 0.000 claims 1
- 239000000463 material Substances 0.000 abstract description 13
- 238000010041 electrostatic spinning Methods 0.000 abstract description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
- 230000000052 comparative effect Effects 0.000 description 34
- 238000012360 testing method Methods 0.000 description 13
- 239000002994 raw material Substances 0.000 description 12
- 206010052428 Wound Diseases 0.000 description 11
- 208000027418 Wounds and injury Diseases 0.000 description 11
- 238000010521 absorption reaction Methods 0.000 description 11
- 150000001408 amides Chemical class 0.000 description 11
- 230000017423 tissue regeneration Effects 0.000 description 9
- 210000001519 tissue Anatomy 0.000 description 8
- 239000000203 mixture Substances 0.000 description 7
- BYEAHWXPCBROCE-UHFFFAOYSA-N 1,1,1,3,3,3-hexafluoropropan-2-ol Chemical compound FC(F)(F)C(O)C(F)(F)F BYEAHWXPCBROCE-UHFFFAOYSA-N 0.000 description 6
- 238000001514 detection method Methods 0.000 description 6
- IOLCXVTUBQKXJR-UHFFFAOYSA-M potassium bromide Chemical compound [K+].[Br-] IOLCXVTUBQKXJR-UHFFFAOYSA-M 0.000 description 6
- 230000008569 process Effects 0.000 description 6
- 241000700159 Rattus Species 0.000 description 5
- 238000010586 diagram Methods 0.000 description 5
- 238000009826 distribution Methods 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 5
- 230000029663 wound healing Effects 0.000 description 5
- 230000007547 defect Effects 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 238000000520 microinjection Methods 0.000 description 4
- 238000009864 tensile test Methods 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 3
- 206010048038 Wound infection Diseases 0.000 description 3
- 239000002131 composite material Substances 0.000 description 3
- 238000002329 infrared spectrum Methods 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 206010015150 Erythema Diseases 0.000 description 2
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 2
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 2
- 108010010803 Gelatin Proteins 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 206010070834 Sensitisation Diseases 0.000 description 2
- 206010070835 Skin sensitisation Diseases 0.000 description 2
- 230000004071 biological effect Effects 0.000 description 2
- 238000004132 cross linking Methods 0.000 description 2
- 231100000321 erythema Toxicity 0.000 description 2
- 210000002744 extracellular matrix Anatomy 0.000 description 2
- 229920000159 gelatin Polymers 0.000 description 2
- 239000008273 gelatin Substances 0.000 description 2
- 235000019322 gelatine Nutrition 0.000 description 2
- 235000011852 gelatine desserts Nutrition 0.000 description 2
- 230000002439 hemostatic effect Effects 0.000 description 2
- 230000005847 immunogenicity Effects 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 238000011069 regeneration method Methods 0.000 description 2
- 231100000241 scar Toxicity 0.000 description 2
- 230000008313 sensitization Effects 0.000 description 2
- 231100000370 skin sensitisation Toxicity 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- 102000012422 Collagen Type I Human genes 0.000 description 1
- 108010022452 Collagen Type I Proteins 0.000 description 1
- 102000016942 Elastin Human genes 0.000 description 1
- 108010014258 Elastin Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 206010062575 Muscle contracture Diseases 0.000 description 1
- 235000003143 Panax notoginseng Nutrition 0.000 description 1
- 241000180649 Panax notoginseng Species 0.000 description 1
- 102000016611 Proteoglycans Human genes 0.000 description 1
- 108010067787 Proteoglycans Proteins 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- 206010040914 Skin reaction Diseases 0.000 description 1
- 206010072170 Skin wound Diseases 0.000 description 1
- 241000251539 Vertebrata <Metazoa> Species 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 238000004378 air conditioning Methods 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000003519 biomedical and dental material Substances 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 125000001309 chloro group Chemical class Cl* 0.000 description 1
- 208000006111 contracture Diseases 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 229920002549 elastin Polymers 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000007490 hematoxylin and eosin (H&E) staining Methods 0.000 description 1
- 231100000086 high toxicity Toxicity 0.000 description 1
- 206010020718 hyperplasia Diseases 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 231100000344 non-irritating Toxicity 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 239000002798 polar solvent Substances 0.000 description 1
- 238000012805 post-processing Methods 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 238000004626 scanning electron microscopy Methods 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 231100000430 skin reaction Toxicity 0.000 description 1
- 230000035483 skin reaction Effects 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
Classifications
-
- D—TEXTILES; PAPER
- D04—BRAIDING; LACE-MAKING; KNITTING; TRIMMINGS; NON-WOVEN FABRICS
- D04H—MAKING TEXTILE FABRICS, e.g. FROM FIBRES OR FILAMENTARY MATERIAL; FABRICS MADE BY SUCH PROCESSES OR APPARATUS, e.g. FELTS, NON-WOVEN FABRICS; COTTON-WOOL; WADDING ; NON-WOVEN FABRICS FROM STAPLE FIBRES, FILAMENTS OR YARNS, BONDED WITH AT LEAST ONE WEB-LIKE MATERIAL DURING THEIR CONSOLIDATION
- D04H1/00—Non-woven fabrics formed wholly or mainly of staple fibres or like relatively short fibres
- D04H1/70—Non-woven fabrics formed wholly or mainly of staple fibres or like relatively short fibres characterised by the method of forming fleeces or layers, e.g. reorientation of fibres
- D04H1/72—Non-woven fabrics formed wholly or mainly of staple fibres or like relatively short fibres characterised by the method of forming fleeces or layers, e.g. reorientation of fibres the fibres being randomly arranged
- D04H1/728—Non-woven fabrics formed wholly or mainly of staple fibres or like relatively short fibres characterised by the method of forming fleeces or layers, e.g. reorientation of fibres the fibres being randomly arranged by electro-spinning
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
- A61L27/24—Collagen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
-
- D—TEXTILES; PAPER
- D01—NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
- D01D—MECHANICAL METHODS OR APPARATUS IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS
- D01D5/00—Formation of filaments, threads, or the like
- D01D5/0007—Electro-spinning
- D01D5/0061—Electro-spinning characterised by the electro-spinning apparatus
-
- D—TEXTILES; PAPER
- D01—NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
- D01D—MECHANICAL METHODS OR APPARATUS IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS
- D01D5/00—Formation of filaments, threads, or the like
- D01D5/0007—Electro-spinning
- D01D5/0061—Electro-spinning characterised by the electro-spinning apparatus
- D01D5/0092—Electro-spinning characterised by the electro-spinning apparatus characterised by the electrical field, e.g. combined with a magnetic fields, using biased or alternating fields
-
- D—TEXTILES; PAPER
- D01—NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
- D01F—CHEMICAL FEATURES IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS; APPARATUS SPECIALLY ADAPTED FOR THE MANUFACTURE OF CARBON FILAMENTS
- D01F4/00—Monocomponent artificial filaments or the like of proteins; Manufacture thereof
-
- D—TEXTILES; PAPER
- D04—BRAIDING; LACE-MAKING; KNITTING; TRIMMINGS; NON-WOVEN FABRICS
- D04H—MAKING TEXTILE FABRICS, e.g. FROM FIBRES OR FILAMENTARY MATERIAL; FABRICS MADE BY SUCH PROCESSES OR APPARATUS, e.g. FELTS, NON-WOVEN FABRICS; COTTON-WOOL; WADDING ; NON-WOVEN FABRICS FROM STAPLE FIBRES, FILAMENTS OR YARNS, BONDED WITH AT LEAST ONE WEB-LIKE MATERIAL DURING THEIR CONSOLIDATION
- D04H1/00—Non-woven fabrics formed wholly or mainly of staple fibres or like relatively short fibres
- D04H1/40—Non-woven fabrics formed wholly or mainly of staple fibres or like relatively short fibres from fleeces or layers composed of fibres without existing or potential cohesive properties
- D04H1/42—Non-woven fabrics formed wholly or mainly of staple fibres or like relatively short fibres from fleeces or layers composed of fibres without existing or potential cohesive properties characterised by the use of certain kinds of fibres insofar as this use has no preponderant influence on the consolidation of the fleece
-
- D—TEXTILES; PAPER
- D04—BRAIDING; LACE-MAKING; KNITTING; TRIMMINGS; NON-WOVEN FABRICS
- D04H—MAKING TEXTILE FABRICS, e.g. FROM FIBRES OR FILAMENTARY MATERIAL; FABRICS MADE BY SUCH PROCESSES OR APPARATUS, e.g. FELTS, NON-WOVEN FABRICS; COTTON-WOOL; WADDING ; NON-WOVEN FABRICS FROM STAPLE FIBRES, FILAMENTS OR YARNS, BONDED WITH AT LEAST ONE WEB-LIKE MATERIAL DURING THEIR CONSOLIDATION
- D04H1/00—Non-woven fabrics formed wholly or mainly of staple fibres or like relatively short fibres
- D04H1/40—Non-woven fabrics formed wholly or mainly of staple fibres or like relatively short fibres from fleeces or layers composed of fibres without existing or potential cohesive properties
- D04H1/42—Non-woven fabrics formed wholly or mainly of staple fibres or like relatively short fibres from fleeces or layers composed of fibres without existing or potential cohesive properties characterised by the use of certain kinds of fibres insofar as this use has no preponderant influence on the consolidation of the fleece
- D04H1/4382—Stretched reticular film fibres; Composite fibres; Mixed fibres; Ultrafine fibres; Fibres for artificial leather
- D04H1/43838—Ultrafine fibres, e.g. microfibres
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2400/00—Materials characterised by their function or physical properties
- A61L2400/12—Nanosized materials, e.g. nanofibres, nanoparticles, nanowires, nanotubes; Nanostructured surfaces
Landscapes
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Textile Engineering (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Transplantation (AREA)
- Animal Behavior & Ethology (AREA)
- Dermatology (AREA)
- Medicinal Chemistry (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Mechanical Engineering (AREA)
- Epidemiology (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Biophysics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Materials For Medical Uses (AREA)
- Artificial Filaments (AREA)
Abstract
Description
技术领域Technical field
本发明属于生物医用材料技术领域,涉及一种含胶原纤维的微纳米纤维膜及其制备方法与应用。The invention belongs to the technical field of biomedical materials and relates to a micro-nano fiber membrane containing collagen fibers and its preparation method and application.
背景技术Background technique
胶原蛋白广泛存在于动物的组织器官中,特别是脊椎动物中,胶原占所有蛋白质含量的30%,由于I型胶原蛋白在生物体内具有可吸收降解、生物相容性及促进组织修复再生的特性,胶原蛋白被作为理想的生物医用材料被广泛应用于组织工程,创伤修复等生物医学领域。Collagen is widely found in animal tissues and organs, especially in vertebrates. Collagen accounts for 30% of all protein content. Type I collagen has the characteristics of absorbable degradation, biocompatibility, and promotion of tissue repair and regeneration in the body. , collagen is used as an ideal biomedical material and is widely used in biomedical fields such as tissue engineering and wound repair.
烧伤或皮肤组织缺损的创面修复多才采用自体或者人工皮肤进行修复,但易形成不同程度的瘢痕增生和挛缩畸形,近年来脱细胞真皮基质作为一种低免疫原性天然胞外基质,去除了细胞成分,保留的胶原蛋白、弹性蛋白和蛋白多糖等大分子可构成复杂3D结构网络,被广泛应用在组织创伤修复领域。Wound repair of burns or skin tissue defects is often done with autologous or artificial skin, but it is easy to form varying degrees of scar hyperplasia and contracture deformity. In recent years, acellular dermal matrix, as a natural extracellular matrix with low immunogenicity, removes cells As a component, the retained macromolecules such as collagen, elastin, and proteoglycans can form a complex 3D structural network and are widely used in the field of tissue wound repair.
静电纺丝法制备的纳米纤维的直径通常在10nm-10μm之间,其孔隙率及空隙连通率非常高,可用来阻挡细菌所致的创伤感染,另外,静电纺丝能够最大程度保留包埋物质的生物活性,提高其生物利用率。The diameter of nanofibers prepared by electrospinning is usually between 10nm and 10μm, and its porosity and interstitial connectivity rate are very high, which can be used to block wound infections caused by bacteria. In addition, electrospinning can retain embedded materials to the greatest extent biological activity and improve its bioavailability.
CN114366844B公开了一种以脱细胞真皮基质为材料,利用酸性复合酶HD-1酶解,与三七素、壳聚糖混合得纺丝液,静电纺丝得复合止血膜材料,由于其酶解获得的胶原蛋白已不具有四级结构——胶原纤维结构,多为分子胶原,如胶原蛋白(Collagen)、明胶(Gelatin)等,均为胶原聚集体的水解产物,通过静电纺丝技术制备得到的胶原分子间缺乏交联,存在力学强度不够、生物相容性问题。且胶原材料的静电纺丝液多选用六氟异丙醇(HFIP)为溶剂,202310919679.3专利公开了以真皮脱细胞外基质为材料,选用六氟异丙醇(HFIP)为溶剂,通过的静电纺丝制备得复合人工皮肤,选用的HFIP作为一种高极性溶剂,在溶解胶原蛋白的同时,会破坏胶原蛋白本身的三股螺旋结构,使其生物活性受到影响,更甚者使其转变为明胶,且力学强度不够的问题。此外,HFIP本身具有的成本高、毒性大、极易挥发的特性,在使用中会损害操作人员健康,污染环境。可见,由于其胶原材料结构的影响,通过静电纺丝技术得到的微纳米纤维膜在力学强度效果和安全性上还是存在一定的问题。CN114366844B discloses a composite hemostatic membrane material made of acellular dermal matrix as a material, enzymatically hydrolyzed by acidic complex enzyme HD-1, mixed with notoginseng and chitosan to obtain a spinning solution, and electrospun to obtain a composite hemostatic membrane material. The obtained collagen no longer has a quaternary structure - collagen fiber structure, but is mostly molecular collagen, such as collagen, gelatin, etc., which are all hydrolyzed products of collagen aggregates and are prepared through electrospinning technology. The collagen molecules lack cross-linking, resulting in insufficient mechanical strength and biocompatibility issues. And the electrospinning solution of collagen materials mostly uses hexafluoroisopropanol (HFIP) as the solvent. The 202310919679.3 patent discloses using dermal decellularized extracellular matrix as the material, using hexafluoroisopropanol (HFIP) as the solvent, and passing the electrospinning Composite artificial skin is prepared from silk. The selected HFIP is a highly polar solvent. While it dissolves collagen, it will destroy the triple helix structure of collagen itself, affecting its biological activity, and even turning it into gelatin. , and the problem of insufficient mechanical strength. In addition, HFIP itself has the characteristics of high cost, high toxicity and high volatility, which will damage the health of operators and pollute the environment during use. It can be seen that due to the influence of its collagen material structure, the micro-nano fiber membrane obtained through electrospinning technology still has certain problems in terms of mechanical strength and safety.
发明内容Contents of the invention
本发明的目的在于提供一种透气性好、可阻挡创伤感染、机械强度好且具有低免疫原性的组织修复胶原微纳米纤维膜及其制备方法。本发明将脱细胞真皮基质与盐水、乙酸和乙醇混合得胶原纤维纺丝液,通过静电纺丝改变了纳米纤维膜的形貌,使其保留原本胶原天然结构,同时具有生物相容性、可降解性及机械强度,可用于组织创面修复领域,另外,本发明所述的胶原微纳米纤维膜与传统的胶原蛋白微纳米纤维膜相比,其机械强度有了显著的提高。The object of the present invention is to provide a tissue repair collagen micro-nano fiber membrane with good air permeability, can block wound infection, good mechanical strength and low immunogenicity and a preparation method thereof. The present invention mixes acellular dermal matrix with saline, acetic acid and ethanol to obtain a collagen fiber spinning liquid. The morphology of the nanofiber membrane is changed through electrospinning so that it retains the original natural structure of collagen and is biocompatible and reproducible. The degradability and mechanical strength can be used in the field of tissue wound repair. In addition, compared with the traditional collagen micro-nano fiber membrane, the mechanical strength of the collagen micro-nano fiber membrane of the present invention has been significantly improved.
基于上述目的,本发明通过提供一种含胶原纤维的微纳米纤维膜及其制备方法,来解决所属领域中的这种需要。Based on the above objectives, the present invention solves this need in the field by providing a micro-nano fiber membrane containing collagen fibers and a preparation method thereof.
一方面,本发明涉及一种含胶原纤维的微纳米纤维膜的制备方法,所述含胶原纤维的微纳米纤维膜的制备方法包括:将脱细胞真皮基质进行高速破壁处理后,制成胶原纤维纺丝液,静电纺丝制得所述含胶原纤维的微纳米纤维膜;所述脱细胞真皮基质进行高速破壁处理的转速25000rpm/min-30000rpm/min,间隔破碎10min-20min。On the one hand, the present invention relates to a method for preparing a micro-nano fiber membrane containing collagen fibers. The method for preparing a micro-nano fiber membrane containing collagen fibers includes: subjecting acellular dermal matrix to high-speed wall-breaking treatment to prepare collagen. Fiber spinning liquid, electrostatic spinning to obtain the micro-nano fiber membrane containing collagen fibers; the acellular dermal matrix is subjected to high-speed wall breaking treatment at a rotation speed of 25000rpm/min-30000rpm/min, with an interval of 10min-20min.
进一步地,本发明提供的一种含胶原纤维的微纳米纤维膜的制备方法中,所述脱细胞真皮基质为异种脱细胞真皮基质。Further, in the method for preparing a micro-nano fiber membrane containing collagen fibers provided by the present invention, the acellular dermal matrix is a heterogeneous acellular dermal matrix.
进一步地,本发明提供的含胶原纤维的微纳米纤维膜的制备方法中,所述胶原纤维纺丝液的制备方法为:脱细胞真皮基质溶解在混合溶液中制得所述胶原纤维纺丝液;所述混合溶液由氯盐、酸、醇和水组成;在包含氯盐、酸、醇和水的混合溶液中,获得胶原纤维纺丝液。Further, in the preparation method of the micro-nano fiber membrane containing collagen fibers provided by the present invention, the preparation method of the collagen fiber spinning liquid is: the acellular dermal matrix is dissolved in the mixed solution to prepare the collagen fiber spinning liquid ; The mixed solution is composed of chloride salt, acid, alcohol and water; in the mixed solution including chloride salt, acid, alcohol and water, a collagen fiber spinning liquid is obtained.
进一步地,本发明提供的一种含胶原纤维的微纳米纤维膜的制备方法中,所述氯盐为氯化钠;所述水为纯水;所述酸为乙酸;所述醇为乙醇。Further, in the preparation method of a collagen fiber-containing micro-nano fiber membrane provided by the present invention, the chloride salt is sodium chloride; the water is pure water; the acid is acetic acid; and the alcohol is ethanol.
进一步地,本发明提供的一种含胶原纤维的微纳米纤维膜的制备方法中,所述胶原纤维纺丝液中胶原纤维的质量分数为5%-10%;所述胶原纤维纺丝液中氯盐的质量分数为0.5%-2.0%;所述胶原纤维纺丝液中水的质量分数为13.20%-23.63%;所述胶原纤维纺丝液中酸的质量分数为47.25%-61.60%;所述胶原纤维纺丝液中醇的质量分数为13.2%-23.63%。Further, in the preparation method of a micro-nano fiber membrane containing collagen fibers provided by the present invention, the mass fraction of collagen fibers in the collagen fiber spinning liquid is 5%-10%; The mass fraction of chloride salt is 0.5%-2.0%; the mass fraction of water in the collagen fiber spinning liquid is 13.20%-23.63%; the mass fraction of acid in the collagen fiber spinning liquid is 47.25%-61.60%; The mass fraction of alcohol in the collagen fiber spinning liquid is 13.2%-23.63%.
进一步地,本发明提供的一种含胶原纤维的微纳米纤维膜制备方法中,所述静电纺丝的参数包括:0.5mL/h-1.0mL/h,纺丝时间为5h-10h,电压为25kV-30kV,接收距离为15cm-20cm。Further, in the preparation method of a micro-nano fiber membrane containing collagen fibers provided by the invention, the electrospinning parameters include: 0.5mL/h-1.0mL/h, the spinning time is 5h-10h, and the voltage is 25kV-30kV, receiving distance is 15cm-20cm.
进一步地,本发明提供的一种含胶原纤维的微纳米纤维膜的制备方法中,所述静电纺丝的环境温度为22℃-28℃,所述静电纺丝的环境湿度为30%-40%。Further, in the preparation method of a micro-nano fiber membrane containing collagen fibers provided by the invention, the ambient temperature of the electrospinning is 22°C-28°C, and the ambient humidity of the electrospinning is 30%-40 %.
进一步地,本发明提供的一种含胶原纤维的微纳米纤维膜的制备方法中,所述静电纺丝的接收器采用滚筒接收器,所述滚筒接收器的转速为300r/min~600r/min。Further, in the preparation method of a micro-nano fiber membrane containing collagen fibers provided by the present invention, the electrospinning receiver adopts a roller receiver, and the rotation speed of the roller receiver is 300r/min~600r/min. .
另一方面,本发明涉及一种微纳米纤维膜,其采用上述任一项所述的含胶原纤维的微纳米纤维膜的制备方法制备得到。On the other hand, the present invention relates to a micro-nano fiber membrane, which is prepared by using the method for preparing a collagen fiber-containing micro-nano fiber membrane described in any one of the above.
另一方面,本发明涉及上述任一项所述的一种含胶原纤维的微纳米纤维膜在创面修复药物制备中的应用。On the other hand, the present invention relates to the application of a collagen fiber-containing micro-nano fiber membrane according to any one of the above in the preparation of wound repair drugs.
本发明与现有技术相比具有以下有益效果或者优点:Compared with the prior art, the present invention has the following beneficial effects or advantages:
本发明以脱细胞真皮基质为原料,采用水、乙酸、乙醇混合溶液作为溶剂,并在其中加入氯盐,制备出含胶原纤维纺丝液,静电纺丝得具组织修复的胶原微纳米纤维膜,所得到的纤维膜材料具有良好的力学性能,生物相容性以及生物可降解性。同时本发明采用的静电纺丝工艺生产设备简单、操作简便,不需要额外的后期处理工艺。本发明所述的组织修复的纤维膜与传统的胶原蛋白纤维膜相比,其力学机械强度有了显著提高,可有效防止创面的感染,尤其组织创面修复效率好且具有低免疫性,安全性强,为静电纺丝制备脱细胞真皮基质来源的胶原纤维膜提供了理论和实验依据,可应用在生物医用材料技术领域。The present invention uses acellular dermal matrix as raw material, uses a mixed solution of water, acetic acid, and ethanol as a solvent, and adds chlorine salt to it to prepare a collagen fiber-containing spinning solution, and electrospinning produces a collagen micro-nano fiber membrane with tissue repair. , the obtained fiber membrane material has good mechanical properties, biocompatibility and biodegradability. At the same time, the electrospinning process used in the present invention has simple production equipment and easy operation, and does not require additional post-processing processes. Compared with the traditional collagen fiber membrane, the tissue repair fiber membrane of the present invention has significantly improved mechanical strength and can effectively prevent wound infection. In particular, the tissue wound repair efficiency is good and has low immunity and safety. Strong, it provides theoretical and experimental basis for electrospinning to prepare collagen fiber membranes derived from acellular dermal matrix, which can be applied in the field of biomedical materials technology.
附图说明Description of the drawings
为了更清楚地说明本发明实施例或现有技术中的技术方案,下面将对实施例或现有技术描述中所需要使用的附图作简单地介绍,显而易见地,下面描述中的附图仅仅是本发明的一些实施例。In order to explain the embodiments of the present invention or the technical solutions in the prior art more clearly, the drawings needed to be used in the description of the embodiments or the prior art will be briefly introduced below. Obviously, the drawings in the following description are only are some embodiments of the invention.
图1为本发明实施例制备的一种含胶原纤维的微纳米纤维膜的扫描电镜图片及纤维直径分布图片。其中A为本发明实施例制备的含胶原纤维的微纳米纤维膜的扫描电镜图片;B为为本发明实施例制备的含胶原纤维的微纳米纤维膜的直径分布图片。Figure 1 is a scanning electron microscope picture and a fiber diameter distribution picture of a micro-nano fiber membrane containing collagen fibers prepared in an embodiment of the present invention. A is a scanning electron microscope picture of the micro-nano fiber membrane containing collagen fibers prepared in the embodiment of the present invention; B is the diameter distribution picture of the micro-nano fiber membrane containing collagen fibers prepared in the embodiment of the present invention.
图2为本发明对比例制备的胶原蛋白的纤维膜的扫描电镜图片和纤维直径分布图片。其中A为本发明对比例制备的含胶原纤维的微纳米纤维膜的扫描电镜图片;B为为本发明对比例制备的含胶原纤维的微纳米纤维膜的直径分布图片。Figure 2 is a scanning electron microscope picture and a fiber diameter distribution picture of the collagen fiber membrane prepared in the comparative example of the present invention. A is a scanning electron microscope picture of the micro-nano fiber membrane containing collagen fibers prepared in the comparative example of the present invention; B is a diameter distribution picture of the micro-nano fiber membrane containing collagen fibers prepared in the comparative example of the present invention.
图3为本发明实施例制备的含胶原纤维的微纳米纤维膜的实物图。Figure 3 is a physical diagram of a micro-nano fiber membrane containing collagen fibers prepared in an embodiment of the present invention.
图4为本发明对比例制备的胶原蛋白的纤维膜的实物图。Figure 4 is a physical diagram of the collagen fiber membrane prepared in the comparative example of the present invention.
图5为本发明实施例制备的微纳米纤维膜和对比例制备的胶原蛋白纤维膜的红外光谱图。Ag-col表示本发明实施例制备的含胶原纤维的微纳米纤维膜的红外光谱图,col表示本发明对比例的胶原蛋白纤维膜的红外光谱图;其中Amide A-酰胺A带吸收峰、Amide B-酰胺B带吸收峰、Amide I-酰胺I带吸收峰、Amide II-酰胺II带吸收峰、Amide III-酰胺III带吸收峰。Figure 5 is an infrared spectrum of the micro-nano fiber membrane prepared in the embodiment of the present invention and the collagen fiber membrane prepared in the comparative example. Ag-col represents the infrared spectrum of the collagen fiber-containing micro-nano fiber membrane prepared in the embodiment of the present invention, col represents the infrared spectrum of the collagen fiber membrane of the comparative example of the present invention; wherein Amide A-amide A band absorption peak, Amide B-amide B band absorption peak, Amide I-amide I band absorption peak, Amide II-amide II band absorption peak, Amide III-amide III band absorption peak.
图6为本发明实施例制备的微纳米纤维膜和对比例制备的胶原蛋白纤维膜的机械拉伸图。Figure 6 is a mechanical stretching diagram of the micro-nano fiber membrane prepared in the embodiment of the present invention and the collagen fiber membrane prepared in the comparative example.
图7为本发明实施例制备的微纳米纤维膜和对比例制备的胶原蛋白纤维膜的伤口愈合图。Figure 7 is a wound healing diagram of the micro-nano fiber membrane prepared in the embodiment of the present invention and the collagen fiber membrane prepared in the comparative example.
图8为本发明实施例制备的微纳米纤维膜和对比例制备的胶原蛋白纤维膜的组织学Masson和H&E染色图。Figure 8 is a histological Masson and H&E staining diagram of the micro-nano fiber membrane prepared in the embodiment of the present invention and the collagen fiber membrane prepared in the comparative example.
具体实施方式Detailed ways
下面,结合实施例对本发明的技术方案进行说明,但是,本发明并不限于下述的实施例。各实施例中所述实验方法和检测方法,如无特殊说明,均为常规方法。所述设备和原料,如无特殊说明,均可在市场上购买得到。The technical solutions of the present invention will be described below with reference to examples. However, the present invention is not limited to the following examples. The experimental methods and detection methods described in each example are conventional methods unless otherwise specified. The equipment and raw materials mentioned above can be purchased in the market unless otherwise specified.
实施例1Example 1
本实施例提供了一种含胶原纤维的微纳米纤维膜的制备方法,包括以下步骤:This embodiment provides a method for preparing a micro-nano fiber membrane containing collagen fibers, which includes the following steps:
步骤1:将冻干后的异种脱细胞真皮基质5g(实验室自制)用剪刀剪成小块,置于23.42ml水(质量分数占23.625%)、45ml乙酸(质量分数占47.25%)、29.94ml(质量分数占23.625%)乙醇组成的混合溶液中,再加入0.5g氯化钠(质量分数占0.5%),浸泡3h,待溶液呈透明状时,得5%胶原纤维的混合液;Step 1: Cut 5g of freeze-dried xenogeneic acellular dermal matrix (made in the laboratory) into small pieces with scissors, place it in 23.42ml water (mass fraction 23.625%), 45ml acetic acid (mass fraction 47.25%), 29.94 ml (mass fraction 23.625%) of ethanol, then add 0.5g sodium chloride (mass fraction 0.5%) and soak for 3 hours. When the solution becomes transparent, a mixture of 5% collagen fibers is obtained;
步骤2:将步骤1得胶原纤维混合液置于高速破壁机中,间隔破碎30min直至得透明胶质状溶液,即为5%胶原纤维纺丝液;Step 2: Place the collagen fiber mixture obtained in step 1 in a high-speed wall breaking machine, and crush it at intervals of 30 minutes until a transparent colloidal solution is obtained, which is a 5% collagen fiber spinning solution;
步骤3:纺丝液加入到静电纺丝系统的注射器中,将注射器安装到微量注射泵上,设置静电纺丝工艺参数:电压为25kV,纺丝液流速为0.5mL/h,接收距离为15cm,纺丝时间5h,纺丝过程中控制环境温度为22℃,环境湿度为30%,滚筒接收器的转速为300r/min,然后开始静电纺丝实验,纺丝结束后在40℃下真空干燥2h,得到所述的含胶原纤维的组织修复纤维膜。Step 3: Add the spinning liquid to the syringe of the electrospinning system, install the syringe on the micro-injection pump, and set the electrospinning process parameters: voltage is 25kV, spinning liquid flow rate is 0.5mL/h, and receiving distance is 15cm , the spinning time is 5 hours. During the spinning process, the ambient temperature is controlled to 22°C, the ambient humidity is 30%, and the rotation speed of the drum receiver is 300r/min. Then the electrospinning experiment is started. After the spinning is completed, it is vacuum dried at 40°C. In 2 hours, the tissue repair fiber membrane containing collagen fibers was obtained.
实施例2Example 2
本实施例提供了一种含胶原纤维的微纳米纤维膜的制备方法,包括以下步骤:This embodiment provides a method for preparing a micro-nano fiber membrane containing collagen fibers, which includes the following steps:
步骤1:将冻干后的异种脱细胞真皮基质8g(实验室自制)用剪刀剪成小块,置于18.16ml水(质量分数占18.16%)、51.89ml乙酸(质量分数占54.48%)、23.02ml(质量分数占18.16%)乙醇组成的混合溶液中,再加入1.2g氯化钠(质量分数占1.2%),浸泡3h,待溶液呈透明状时,得8%胶原纤维的混合液;Step 1: Cut 8g of freeze-dried xenogeneic acellular dermal matrix (made in the laboratory) into small pieces with scissors, and place it in 18.16ml water (mass fraction 18.16%), 51.89ml acetic acid (mass fraction 54.48%), Add 1.2g sodium chloride (mass fraction 1.2%) to a mixed solution composed of 23.02ml (mass fraction 18.16%) ethanol, and soak for 3 hours. When the solution becomes transparent, a mixed solution of 8% collagen fiber is obtained;
步骤2:将步骤1得胶原纤维混合液置于高速破壁机中,间隔搅拌30min直至得透明胶质状溶液,即为8%胶原纤维纺丝液;Step 2: Place the collagen fiber mixture obtained in step 1 into a high-speed wall breaking machine and stir for 30 minutes at intervals until a transparent colloidal solution is obtained, which is the 8% collagen fiber spinning solution;
步骤3:纺丝液加入到静电纺丝系统的注射器中,将注射器安装到微量注射泵上,设置静电纺丝工艺参数:电压为27kV,纺丝液流速为0.8mL/h,接收距离为18cm,纺丝时间10h,纺丝过程中控制环境温度为25℃,环境湿度为35%,滚筒接收器的转速为500r/min,然后开始静电纺丝实验,纺丝结束后在40℃下真空干燥2h,得到所述的含胶原纤维的组织修复纤维膜。Step 3: Add the spinning liquid to the syringe of the electrospinning system, install the syringe on the micro-injection pump, and set the electrospinning process parameters: voltage is 27kV, spinning liquid flow rate is 0.8mL/h, and receiving distance is 18cm , the spinning time is 10h, during the spinning process, the ambient temperature is controlled to 25°C, the ambient humidity is 35%, the rotation speed of the drum receiver is 500r/min, and then the electrospinning experiment is started, and after the spinning is completed, it is vacuum dried at 40°C In 2 hours, the tissue repair fiber membrane containing collagen fibers was obtained.
实施例3Example 3
本实施例提供了一种含胶原纤维的微纳米纤维膜的制备方法,包括以下步骤:This embodiment provides a method for preparing a micro-nano fiber membrane containing collagen fibers, which includes the following steps:
步骤1:将冻干后的异种脱细胞真皮基质10g(实验室自制)用剪刀剪成小块,置于13.20ml水(质量分数占13.20%)、58.67ml乙酸(质量分数占61.60%)、16.92ml(质量分数占13.20%)乙醇组成的混合溶液中,再加入2.0g氯化钠(质量分数占2.0%),浸泡3h,待溶液呈透明状时,得10%胶原纤维的混合液;Step 1: Cut 10g of freeze-dried xenogeneic acellular dermal matrix (made in the laboratory) into small pieces with scissors, and place it in 13.20ml water (mass fraction 13.20%), 58.67ml acetic acid (mass fraction 61.60%), Add 2.0g sodium chloride (mass fraction 2.0%) to a mixed solution composed of 16.92ml (mass fraction 13.20%) ethanol, and soak for 3 hours. When the solution becomes transparent, a mixed solution of 10% collagen fiber is obtained;
步骤2:将步骤1得胶原纤维混合液置于高速破壁机中,间隔搅拌30min直至得透明胶质状溶液,即为10%胶原纤维纺丝液;Step 2: Place the collagen fiber mixture obtained in step 1 into a high-speed wall breaking machine and stir for 30 minutes at intervals until a transparent colloidal solution is obtained, which is the 10% collagen fiber spinning solution;
步骤3:纺丝液加入到静电纺丝系统的注射器中,将注射器安装到微量注射泵上,设置静电纺丝工艺参数:电压为30kV,纺丝液流速为1.0mL/h,接收距离为20cm,纺丝时间8h,纺丝过程中控制环境温度为28℃、环境湿度为40%,滚筒接收器的转速为600r/min;然后开始静电纺丝实验,纺丝结束后在40℃下真空干燥2h,得到所述的含胶原纤维的组织修复纤维膜。Step 3: Add the spinning liquid to the syringe of the electrospinning system, install the syringe on the micro-injection pump, and set the electrospinning process parameters: voltage is 30kV, spinning liquid flow rate is 1.0mL/h, and receiving distance is 20cm , the spinning time is 8 hours, during the spinning process, the ambient temperature is controlled to 28°C, the ambient humidity is 40%, and the rotation speed of the drum receiver is 600r/min; then the electrospinning experiment is started, and after the spinning is completed, it is vacuum dried at 40°C In 2 hours, the tissue repair fiber membrane containing collagen fibers was obtained.
对比例1Comparative example 1
本对比例意图通过传统的胶原蛋白静电纺丝制备的纤维膜与本发明中以脱细胞真皮基质为原料制备的胶原纤维膜的机械强度的比较,来说明传统的分子胶原通过静电纺丝技术制备得到的胶原分子间缺乏交联,存在力学强度不够问题,本对比例提供了一种含传统胶原蛋白的纤维膜的制备方法,包括以下步骤:This comparative example is intended to illustrate the preparation of traditional molecular collagen through electrospinning technology by comparing the mechanical strength of the fiber membrane prepared by traditional collagen electrospinning with the collagen fiber membrane prepared by using acellular dermal matrix as raw material in the present invention. The obtained collagen molecules lack cross-linking and have insufficient mechanical strength. This comparative example provides a method for preparing a fibrous membrane containing traditional collagen, which includes the following steps:
步骤1:将5g胶原蛋白(购自上海麦克林),置于18.90ml水(质量分数占18.90%)、54.00ml乙酸(质量分数占56.70%)、23.95ml(质量分数占18.90%)乙醇组成的混合溶液中,再加入0.5g氯化钠(质量分数占0.5%),浸泡3h,待溶液呈透明状时,得5%胶原蛋白的混合液;Step 1: Place 5g of collagen (purchased from Shanghai McLean) into a mixture of 18.90ml water (mass fraction 18.90%), 54.00ml acetic acid (mass fraction 56.70%), and 23.95ml ethanol (mass fraction 18.90%). To the mixed solution, add 0.5g sodium chloride (mass fraction 0.5%) and soak for 3 hours. When the solution becomes transparent, a 5% collagen mixed solution is obtained;
步骤2:将步骤1得胶原蛋白混合液置于高速破壁机中,间隔搅拌30min直至得透明胶质状溶液,即为5%胶原纤维纺丝液;Step 2: Place the collagen mixture obtained in step 1 into a high-speed wall breaking machine and stir for 30 minutes at intervals until a transparent colloidal solution is obtained, which is a 5% collagen fiber spinning solution;
步骤3:纺丝液加入到静电纺丝系统的注射器中,将注射器安装到微量注射泵上,设置静电纺丝工艺参数:电压为25kV,纺丝液流速为0.5mL/h,接收距离为15cm,纺丝时间5h,纺丝过程中控制环境温度为22℃,环境湿度为30%,滚筒接收器的转速为300r/min,然后开始静电纺丝实验,纺丝结束后在40℃下真空干燥2h,得含传统胶原蛋白的纤维膜。Step 3: Add the spinning liquid to the syringe of the electrospinning system, install the syringe on the micro-injection pump, and set the electrospinning process parameters: voltage is 25kV, spinning liquid flow rate is 0.5mL/h, and receiving distance is 15cm , the spinning time is 5 hours. During the spinning process, the ambient temperature is controlled to 22°C, the ambient humidity is 30%, and the rotation speed of the drum receiver is 300r/min. Then the electrospinning experiment is started. After the spinning is completed, it is vacuum dried at 40°C. After 2 hours, a fibrous membrane containing traditional collagen was obtained.
实施例4Example 4
本实施例提供了实施例1-3制备的一种含胶原纤维的微纳米纤维膜与对比例1以传统胶原蛋白制备的纤维膜的扫描电镜试验。This example provides a scanning electron microscope test of a micro-nano fiber membrane containing collagen fibers prepared in Examples 1-3 and a fiber membrane prepared with traditional collagen in Comparative Example 1.
扫描电镜试验方法:Scanning electron microscope test method:
本发明实施例1-3制备的一种含胶原纤维的微纳米纤维膜与对比例1以传统胶原蛋白为原料静电纺丝的纤维膜进行扫描电镜试验,设置其工作距离(WD)为10.6mm观测其多孔结构,实施例制备的含胶原纤维的微纳米纤维膜的扫描电镜结果和纤维直径分布结果如图1所示,实施例制备的含胶原纤维的微纳米纤维膜的实物图如图3所示。对比例1的纤维膜扫描电镜结果和纤维直径结果如图2所示,对比例1的纤维膜实物图如图4所示。由图1可知,测得实施例的纤维膜孔隙率65.63%,直径0.186μm。由图2可知,测得对比例的纤维膜孔隙率71.03%,直径0.113μm。由两者电镜扫描结果对比可知,本发明实施例1-3制备的一种含胶原纤维的微纳米纤维膜与对比例制备的纤维膜的结果对比意图说明电纺液分子量的提高可以增大纤维直径,纤维直径的增大可以提高纤维间的相互接触面积,增大纤维间的摩擦,使得纤维膜强度有一定提高。由图3、图4结果可知,两者对比意图说明随着纤维直径增大,纤维膜表面缺陷减少,实施例1-3制备的含胶原纤维的微纳米纤维膜表面缺陷更少,可以有效避免应力集中现象。A micro-nano fiber membrane containing collagen fibers prepared in Examples 1-3 of the present invention and a fiber membrane electrospun from traditional collagen as raw material in Comparative Example 1 were subjected to scanning electron microscopy tests, and the working distance (WD) was set to 10.6 mm. The porous structure was observed. The scanning electron microscope results and fiber diameter distribution results of the micro-nano fiber membrane containing collagen fibers prepared in the Example are shown in Figure 1. The physical picture of the micro-nano fiber membrane containing collagen fibers prepared in the Example is shown in Figure 3. shown. The scanning electron microscope results and fiber diameter results of the fiber membrane of Comparative Example 1 are shown in Figure 2, and the physical picture of the fiber membrane of Comparative Example 1 is shown in Figure 4. It can be seen from Figure 1 that the porosity of the fiber membrane of the example was measured to be 65.63% and the diameter was 0.186 μm. As can be seen from Figure 2, the porosity of the fiber membrane of the comparative example was measured to be 71.03%, and the diameter was 0.113 μm. It can be seen from the comparison of the electron microscope scanning results of the two that the results of a micro-nano fiber membrane containing collagen fibers prepared in Examples 1-3 of the present invention and the fiber membrane prepared in the comparative example are intended to illustrate that increasing the molecular weight of the electrospinning solution can increase the size of the fiber. Diameter, the increase in fiber diameter can increase the mutual contact area between fibers, increase the friction between fibers, and improve the strength of the fiber membrane to a certain extent. It can be seen from the results of Figure 3 and Figure 4 that the comparison between the two illustrates that as the fiber diameter increases, the surface defects of the fiber membrane decrease. The micro-nano fiber membrane containing collagen fibers prepared in Examples 1-3 has fewer surface defects and can be effectively avoided. Stress concentration phenomenon.
实施例5Example 5
本实施例提供了实施例1-3制备的一种含胶原纤维的微纳米纤维膜与对比例1以传统胶原蛋白为原料静电纺丝的纤维膜的红外检测试验。This example provides an infrared detection test of a micro-nano fiber membrane containing collagen fibers prepared in Examples 1-3 and a fiber membrane electrospun in Comparative Example 1 using traditional collagen as raw material.
红外检测方法:Infrared detection method:
本发明实施例1-3制备的一种含胶原纤维的微纳米纤维膜与对比例1以传统胶原蛋白为原料静电纺丝的纤维膜进行红外检测试验,采用溴化钾(KBr)压片法进行分析,取100mgKBr晶体与2mg Ag-col和Col分别混合研磨、压片,在室温(24±1℃),干燥环境(相对湿度低于65%)下,4000cm-1-400cm-1波数段扫描32次取平均值,分辨率设置为4cm-1。实施例和对比例的红外检测结果图像如图5所示。由图5可知,Ag-col和Col的酰胺I带的红外吸收峰分别出现在1662cm-1和1657cm-1处;酰胺II带的吸收峰分别集中在,1559cm-1和1544cm-1处;而酰胺III带的吸收峰均出现了波数为1241cm-1处;酰胺A带的吸收峰分别出现在3538cm-1和3436cm-1处;酰胺B带的特征吸收峰分别出现在3053cm-1和3049cm-1处。由两者红外测试结果对比可知,本发明制备的一种含胶原纤维的微纳米纤维膜与对比例制备的纤维膜的结果对比意图说明两者的酰胺带特征吸收峰都明显存在,且差别不大,证实了两种材料的基本二级结构类似,天然的三股螺旋结构保留完整。A micro-nano fiber membrane containing collagen fibers prepared in Examples 1-3 of the present invention and a fiber membrane electrospun from traditional collagen as raw material in Comparative Example 1 were subjected to infrared detection tests, using the potassium bromide (KBr) tableting method. For analysis, take 100 mg of KBr crystals, mix them with 2 mg of Ag-col and Col, grind and press them into tablets. At room temperature (24±1°C) and in a dry environment (relative humidity less than 65%), the wave number range is 4000cm -1 -400cm -1 Scan 32 times to take the average, and the resolution is set to 4cm -1 . The infrared detection result images of the examples and comparative examples are shown in Figure 5. It can be seen from Figure 5 that the infrared absorption peaks of the amide I band of Ag-col and Col appear at 1662cm -1 and 1657cm -1 respectively; the absorption peaks of the amide II band are concentrated at 1559cm -1 and 1544cm -1 respectively; and The absorption peaks of the amide III band all appear at a wave number of 1241cm -1 ; the absorption peaks of the amide A band appear at 3538cm -1 and 3436cm -1 respectively; the characteristic absorption peaks of the amide B band appear at 3053cm -1 and 3049cm - respectively. 1 place. From the comparison of the infrared test results of the two, it can be seen that the comparison of the results of a micro-nano fiber membrane containing collagen fibers prepared by the present invention and the fiber membrane prepared by the comparative example shows that the characteristic absorption peaks of the amide band of both are obviously present, and there is no difference. Large, confirming that the basic secondary structures of the two materials are similar, and the natural triple helix structure remains intact.
实施例6Example 6
本实施例提供了实施例1-3制备的一种含胶原纤维的微纳米纤维膜与对比例1以传统胶原蛋白为原料静电纺丝的纤维膜的机械拉伸试验。This example provides a mechanical tensile test of a micro-nano fiber membrane containing collagen fibers prepared in Examples 1-3 and a fiber membrane electrospun in Comparative Example 1 using traditional collagen as raw material.
机械拉伸试验方法:Mechanical tensile test method:
本发明实施例制备的一种含胶原纤维的微纳米纤维膜与对比例1以传统胶原蛋白为原料静电纺丝的纤维膜进行机械拉伸试验,采用恒速拉伸法,选用中号哑铃式样模刀,将伺服材料多功能高低温控制试验机设置20mm/min恒速拉伸,空气调节温度23±2℃,相对湿度为50±5℃。实施例1-3和对比例1的红外检测结果图像如图6所示。由图6可知,试验组中实施例1-3的机械强度均高于对比例1,通过抗张强度的计算可得实施例1-3制备含胶原纤维的微纳米纤维膜的抗张强度分别为48.76kPa、51.32kPa、46.42kPa,对比例1制备的以胶原蛋白为原料静电纺丝制备的纤维膜的抗张强度为37.73kPa。由两者机械拉伸试验测试结果对比可知,本发明实施例1-3制备的一种含胶原纤维的微纳米纤维膜与对比例1制备的纤维膜的结果对比,意图说明本发明制备的含胶原纤维的微纳米纤维膜的机械性能较高。A kind of micro-nano fiber membrane containing collagen fiber prepared in the embodiment of the present invention and Comparative Example 1. A fiber membrane electrospun with traditional collagen as raw material was subjected to a mechanical tensile test. A constant speed stretching method was used, and a medium dumbbell style was selected. Die cutter, set the servo material multifunctional high and low temperature control testing machine to 20mm/min constant speed stretching, the air conditioning temperature is 23±2℃, and the relative humidity is 50±5℃. The infrared detection result images of Examples 1-3 and Comparative Example 1 are shown in Figure 6. It can be seen from Figure 6 that the mechanical strength of Examples 1-3 in the test group is higher than that of Comparative Example 1. By calculating the tensile strength, the tensile strengths of the micro-nanofiber membranes containing collagen fibers prepared in Examples 1-3 can be obtained, respectively. are 48.76kPa, 51.32kPa, and 46.42kPa. The tensile strength of the fiber membrane prepared by electrospinning of collagen as raw material in Comparative Example 1 is 37.73kPa. It can be seen from the comparison of the mechanical tensile test results of the two that the results of a micro-nano fiber membrane containing collagen fibers prepared in Examples 1-3 of the present invention and the fiber membrane prepared in Comparative Example 1 are intended to illustrate that the collagen fiber-containing micro-nano fiber membrane prepared in Examples 1-3 of the present invention is The micro-nano fiber membrane of collagen fibers has higher mechanical properties.
实施例7Example 7
本实施例提供了实施例1-3制备的一种含胶原纤维的微纳米纤维膜与对比例1以传统胶原蛋白为原料静电纺丝的纤维膜的皮肤致敏试验和创面组织修复试验。This example provides a skin sensitization test and a wound tissue repair test of a micro-nano fiber membrane containing collagen fibers prepared in Examples 1-3 and a fiber membrane electrospun from traditional collagen as raw material in Comparative Example 1.
(1)皮肤致敏试验(1) Skin sensitization test
根据GB/T 16886.10-2005/ISO 10993-10:2002进行致敏试验,将4只健康白鼠去除背部毛发,分别取0.5g实施例1-3、对比例1制备的纤维膜置于脊柱左侧皮肤,以生理盐水为对照组,涂覆于脊柱右侧皮肤,用纱布覆盖接触部位,并用绷带固定贴片至少4h,在去除贴片的1h、24h、48h、72h记录各接触部位情况。致敏试验结果用肉眼观察可得,与对照组相比,实施,1-3和对比例1处理后的动物皮肤1h、24h、48h、72h均无出现红斑、水肿等皮肤反应。结果表明,本发明实施例1-3制备的一种含胶原纤维的微纳米纤维膜和对比例1以传统胶原蛋白为原料静电纺丝的纤维膜均无皮肤刺激性。A sensitization test was conducted according to GB/T 16886.10-2005/ISO 10993-10:2002. The back hair of 4 healthy white mice was removed, and 0.5g of the fiber membrane prepared in Examples 1-3 and Comparative Example 1 was placed on the left side of the spine. For skin, use normal saline as the control group. Apply it to the skin on the right side of the spine. Cover the contact site with gauze and fix the patch with a bandage for at least 4 hours. Record the conditions of each contact site at 1h, 24h, 48h, and 72h after removing the patch. The results of the sensitization test can be observed with the naked eye. Compared with the control group, the skin of animals treated with 1-3 and Comparative Example 1 did not have erythema, edema and other skin reactions at 1h, 24h, 48h, and 72h. The results show that neither the micro-nano fiber membrane containing collagen fiber prepared in Examples 1-3 of the present invention nor the fiber membrane electrospun from traditional collagen as raw material in Comparative Example 1 has any skin irritation.
(2)创面修复试验(2)Wound repair test
将SD大鼠背部毛发剔除,用碘酒进行皮肤消毒后,使用圆形动物皮肤打孔器在SD大鼠背部制造直径8mm的圆形全层皮肤缺损。实施例1-3制备的含胶原纤维微纳米纤维膜为实验组,对比例1以传统胶原蛋白静电纺丝的纤维膜为对照组,空白组为不处理组,待伤口自然愈合,分别对伤口进行覆盖粘合治疗,最后用医用手术薄膜包扎。观察并记录SD大鼠伤口愈合情况。在第14天,切取SD大鼠伤口部位组织,进行Masson和H&E染色。实施例1-3制备的含胶原纤维的微纳米纤维膜覆盖的伤口、对比例1以胶原蛋白制备的纤维膜覆盖的伤口和空白组的伤口愈合结果图像如图7所示,组织学染色图像如图8所示。由图7可知,前3天伤口变化无明显差异,第9天,与对照组相比,实施例实验组伤口明显变小,第14天对照组的SD大鼠创面未完全愈合,仍有红色创面裸露,未被新生皮肤覆盖,而实验组创面已基本愈合,表面无瘢痕组织,无红斑水肿现象。由图8可知,实验组的上皮再生较对照组更完整,实验组的胶原蛋白沉积率更高。结果表明,本发明制备的含胶原纤维的微纳米纤维膜和以传统胶原蛋白为原料静电纺丝的纤维膜均对皮肤创面愈合有一定的促进作用,本发明制备的含胶原纤维的微纳米纤维膜的促进伤口愈合的作用更强,且无皮肤刺激性。The hair on the back of the SD rat was removed, and after the skin was disinfected with iodine, a circular animal skin punch was used to create a circular full-thickness skin defect with a diameter of 8 mm on the back of the SD rat. The micro-nano fiber membranes containing collagen fibers prepared in Examples 1-3 were used as the experimental group. In Comparative Example 1, the traditional collagen electrospun fiber membranes were used as the control group. The blank group was the untreated group. After the wounds healed naturally, the wounds were treated respectively. Cover and bond treatment, and finally wrap with medical surgical film. Observe and record the wound healing status of SD rats. On the 14th day, tissue from the wound site of SD rats was cut and stained with Masson and H&E. The wound healing result images of the wounds covered by the micro-nano fiber membranes containing collagen fibers prepared in Examples 1-3, the wounds covered by the fiber membranes prepared by collagen in Comparative Example 1 and the blank group are shown in Figure 7, and histological staining images As shown in Figure 8. As can be seen from Figure 7, there was no significant difference in the wound changes in the first 3 days. On the 9th day, compared with the control group, the wound of the experimental group of the Example was significantly smaller. On the 14th day, the wound of the SD rat in the control group was not completely healed and was still red. The wounds were exposed and not covered by new skin, while the wounds in the experimental group had basically healed, with no scar tissue on the surface and no erythema and edema. As can be seen from Figure 8, the epithelial regeneration in the experimental group was more complete than that in the control group, and the collagen deposition rate in the experimental group was higher. The results show that both the micro-nano fiber membranes containing collagen fibers prepared by the present invention and the electrospun fiber membranes using traditional collagen as raw materials have a certain promoting effect on skin wound healing. The micro-nano fiber membranes containing collagen fibers prepared by the present invention The membrane has a stronger effect on promoting wound healing and is non-irritating to the skin.
如上所述,即可较好地实现本发明,上述的实施例仅仅是对本发明的优选实施方式进行描述,并非对本发明的范围进行限定,在不脱离本发明设计精神的前提下,本领域普通技术人员对本发明的技术方案做出的各种改变和改进,均应落入本发明确定的保护范围。As described above, the present invention can be better implemented. The above-mentioned embodiments are only descriptions of preferred embodiments of the present invention and do not limit the scope of the present invention. Without departing from the design spirit of the present invention, ordinary people in the art can Various changes and improvements made by skilled personnel to the technical solutions of the present invention should fall within the defined protection scope of the present invention.
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202311481754.9A CN117569013A (en) | 2023-11-08 | 2023-11-08 | Micro-nano fiber membrane containing collagen fibers and preparation method and application thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202311481754.9A CN117569013A (en) | 2023-11-08 | 2023-11-08 | Micro-nano fiber membrane containing collagen fibers and preparation method and application thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN117569013A true CN117569013A (en) | 2024-02-20 |
Family
ID=89883479
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202311481754.9A Pending CN117569013A (en) | 2023-11-08 | 2023-11-08 | Micro-nano fiber membrane containing collagen fibers and preparation method and application thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN117569013A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN117802696A (en) * | 2024-03-01 | 2024-04-02 | 中国农业大学 | Zein nanofiber membrane and preparation method thereof |
-
2023
- 2023-11-08 CN CN202311481754.9A patent/CN117569013A/en active Pending
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN117802696A (en) * | 2024-03-01 | 2024-04-02 | 中国农业大学 | Zein nanofiber membrane and preparation method thereof |
CN117802696B (en) * | 2024-03-01 | 2024-05-28 | 中国农业大学 | A zein nanofiber membrane, preparation method and application thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP3015120B1 (en) | Tissue repair scaffold and preparation method and purpose thereof | |
Liu et al. | Bioactive wound dressing based on decellularized tendon and GelMA with incorporation of PDA-loaded asiaticoside nanoparticles for scarless wound healing | |
JP5246878B2 (en) | Artificial eardrum using silk protein | |
CN103418021B (en) | In-situ-crossly-linked electrospun fibrous membrane dressing made from collangen I and preparation method of in-situ crosslinking electrospun fibrous membrane dressing | |
US11298309B2 (en) | Topical silk compositions and methods of using | |
CN103263694B (en) | Collagen-based dura and preparation method thereof | |
TW200925342A (en) | Method for production of nanofibres | |
CN107823692B (en) | Wound dressing composite nanofiber membrane and preparation method thereof | |
Xie et al. | Allantoin-functionalized silk fibroin/sodium alginate transparent scaffold for cutaneous wound healing | |
Li et al. | A native sericin wound dressing spun directly from silkworms enhances wound healing | |
CN108478866A (en) | Tissue recovery support, preparation method and use | |
CN106039416A (en) | Chitosan-sericin composite biological scaffold as well as preparation method and application thereof | |
Kazemi et al. | Core-shell nanofibers containing L-arginine stimulates angiogenesis and full thickness dermal wound repair | |
CN115177778B (en) | Composite wound dressing, preparation method and application | |
CN106421903A (en) | Blue shark fishskin collagen periodontium guided regeneration nanofiber membrane and preparing method thereof | |
CN107320776A (en) | A kind of gel for promoting corium regeneration and preparation method thereof | |
CN109381732A (en) | Electrostatic spinning dressing, preparation method and the application of growth factor-loaded micromolecular inhibitor | |
CN109853130A (en) | The ultra-thin super stemness nano fibrous membrane paper of one kind and preparation method | |
Yuan et al. | Homogeneous and efficient production of a bacterial nanocellulose-lactoferrin-collagen composite under an electric field as a matrix to promote wound healing | |
Valentino et al. | Formulation development of collagen/chitosan-based porous scaffolds for skin wounds repair and regeneration | |
CN117569013A (en) | Micro-nano fiber membrane containing collagen fibers and preparation method and application thereof | |
CN107737364A (en) | A kind of wound dressing and preparation method thereof | |
CN107496972A (en) | A kind of moist dressing and preparation method thereof that prevents adhesion for promoting burn wound healing | |
CN104548188A (en) | Hyaluronic acid-nano silver-based dressing and preparation method thereof | |
CN111388742A (en) | Collagen dressing capable of releasing antibiotics in sustained and controlled manner and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |